Possible suppression of host resistance by estrogen therapy for prostatic cancer.
D003864:Depression, Chemical; D004967:Estrogens / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007165:Immunosuppression Therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000276:immunology
D004967:Estrogens